EN
ES

Newsroom

GENESIS Biomed, sponsor of BIOSPAIN 2025, has been involved in the event with active participation

GENESIS Biomed, sponsor of BIOSPAIN 2025, has been involved in the event with active participation

...

16 October, 2025

Rafael Navajo - Director of Innovation and Business Development Area at VHIR (Vall d'Hebron Research Institute)

Rafael Navajo – Director of Innovation and Business Development Area at VHIR (Vall d’Hebron Research Institute)

...

18 September, 2025

The microbiota revolution

The microbiota revolution

...

04 September, 2025

EHDS: A revolution in health data management

EHDS: A revolution in health data management

...

17 July, 2025

Maria Terrades Palomar - CEO of the PCB (Parc Científic de Barcelona).

Interview Maria Terrades Palomar – CEO of the PCB (Parc Científic de Barcelona)

...

10 July, 2025

GENESIS Biomed participated in the valuation of CellsIA, a company acquired by Laboratorios ROVI

GENESIS Biomed participated in the valuation of CellsIA, a company acquired by Laboratorios ROVI

...

19 June, 2025

Glòria Oliver Rodríguez - Deputy CEO of the Pasqual Maragall Foundation.

Interview Glòria Oliver Rodríguez – Deputy CEO of the Pasqual Maragall Foundation

...

05 June, 2025

GENESIS Biomed holds its 2025 Annual Symposium at the Parc Científic de Barcelona

GENESIS Biomed holds its 2025 Annual Symposium at the Parc Científic de Barcelona

...

22 May, 2025

Prevention versus Therapy. The breakthrough of the current century

Prevention versus Therapy. The breakthrough of the current century

...

12 May, 2025

Convertible Note vs. Capital Increase

Convertible Note vs. Capital Increase

...

10 April, 2025

New Pandemics: Are we prepared?

New Pandemics: Are we prepared?

...

20 March, 2025

What do they say about us?

What do they say about us?

...

13 March, 2025

Business growth

Business growth

...

20 February, 2025

Interview Maite Fibla - Co-founder of Ship2B Foundation and Co-Founder-Managing Partner of Ship2B Ventures

Interview Maite Fibla. Co-founder of Ship2B Foundation and Co-Founder/Managing Partner of Ship2B Ventures

...

06 February, 2025

Jornada anual GENESIS Biomed 2025

Jornada anual GENESIS Biomed 2025 Barcelona, 15 de mayo

...

03 February, 2025

GENESIS Biomed advised Corify Care on the closing of its latest €6M investment round last December

GENESIS Biomed advised Corify Care on the closing of its latest €6M investment round last December

...

23 January, 2025

Interview with Dr. Francisco Fernández-Avilés - Professor of Cardiovascular Medicine at the Complutense University of Madrid and Co-Founder of Corify Care

Interview Francisco Fernández-Avilés – Professor of Cardiovascular Medicine at the UCM and Co-Founder of Corify Care

...

16 January, 2025

GENESIS Biomed positions itself as a key player for the growth and dynamisation of the ecosystem of innovation in health

GENESIS Biomed positions itself as a key player for the growth and dynamisation of the ecosystem of innovation in health

...

12 December, 2024

Events 2024

...

09 December, 2024

GENESIS Biomed sponsors the 3rd Conference on Healthcare Entrepreneurship at the Gregorio Marañón Health Research Institute

GENESIS Biomed sponsors the 3rd Conference on Healthcare Entrepreneurship at the Gregorio Marañón Health Research Institute

...

28 November, 2024

The data revolution and AI in the Health sector

The data revolution and AI in the Health sector

...

14 November, 2024

Interview Alfons Carnicero -CEO and Co-Founder of ABLE Human Motion

Interview Alfons Carnicero -CEO and Co-Founder of ABLE Human Motion

...

24 October, 2024

Interview David Segarra - CEO and Co-Founder of aptaTargets

Interview David Segarra – CEO and Co-Founder of aptaTargets

...

09 October, 2024

Cash Need and Valuation: two key elements for a successful Investment Round

Cash Need and Valuation: two key elements for a successful Investment Round

...

26 September, 2024

Biological Sex Differences in Health: Challenges and Opportunities for Personalised Medicine

Biological Sex Differences in Health: Challenges and Opportunities for Personalised Medicine

...

05 September, 2024

Open Innovation in pharmaceutical R&D

What is Open Innovation in pharmaceutical R&D?

...

18 July, 2024

A complementary and natural approach to conventional medicine: Herbal medicinal products

A complementary and natural approach to conventional medicine: Herbal medicinal products

...

20 June, 2024

Interview Rafael Simó - Head of the Endocrinology and Nutrition Department at Vall d'Hebron University Hospital

Interview Rafael Simó – Head of the Endocrinology and Nutrition Department at Vall d’Hebron University Hospital

...

06 June, 2024

De izquierda a derecha: Dr. Manuel Desco (Cofundador); Dr. Jesús García-Foncillas (Cofundador); Ana Ye (CEO y Cofundadora); Joaquín Solanes (Partner y Asesor Financiero); Alfredo Azabal (CTO)

GENESIS Tech Transfer Boost invests €50,000 in the funding round of Ownmed Innovation, which closes with a total of €630,000

...

23 May, 2024

Interview Julio Mayol - Professor of Surgery at the Complutense University of Madrid and Head of the Colorectal Surgery Section at the Hospital Clínico San Carlos

Interview Julio Mayol – Professor of Surgery at the Complutense University of Madrid and Head of the Colorectal Surgery Section at the Hospital Clínico San Carlos

...

16 May, 2024

The growth of Clusters in the field of Biomedicine in Spain

...

29 April, 2024

Interview Lluís Blanch - Director of the Institut d'Investigació i Innovació I3PT and current Coordinator of the ITEMAS Platform - ISCIII

Interview Lluís Blanch – Director of the Institut d’Investigació i Innovació I3PT and current Coordinator of the ITEMAS Platform – ISCIII

...

11 April, 2024

Interview Rafael Cantón - Head of the Clinical Microbiology Service at the Ramón y Cajal University Hospital

Interview Rafael Cantón – Head of the Clinical Microbiology Service at the Ramón y Cajal University Hospital

...

21 March, 2024

Augmented Reality and Virtual Reality in the field of Healthcare

Augmented Reality and Virtual Reality in the field of Healthcare

...

14 March, 2024

What do they say about us?

What do they say about us?

...

22 February, 2024

GENESIS Tech Transfer Boost invests €50,000 in the start-up Affirma Biotech

GENESIS Tech Transfer Boost invests €50,000 in the start-up Affirma Biotech

...

01 February, 2024

GENESIS Tech Transfer Boost incorporates a new investment partner, PINONO S.L.

GENESIS Tech Transfer Boost incorporates a new investment partner, PINONO S.L.

...

26 January, 2024

Video Genesis Biomed Biohub VLC

Jornada Anual GENESIS Biomed 2023 Valencia

...

23 January, 2024

Success stories of GENESIS Biomed as Venture Builder

Success stories of GENESIS Biomed as Venture Builder

...

11 January, 2024

Innovation in mental health

Innovation in Mental Health

...

14 December, 2023

GENESIS Biomed kicks-off its new site at Valencia and holds its Annual Conference

GENESIS Biomed kicks-off its new site at Valencia and holds its Annual Conference

...

22 November, 2023

Team Genesis Biomed

GENESIS Biomed consolidates its growth in the biomedical sector

...

17 November, 2023

GENESIS Biomed sponsors, for the second consecutive year, the Healthcare Entrepreneurship Conference Day at Gregorio Marañón Health Research Institute

GENESIS Biomed sponsors, for the second consecutive year, the Healthcare Entrepreneurship Conference Day at Gregorio Marañón Health Research Institute

...

20 October, 2023

GENESIS Biomed is part of the EU-funded PHEMS project consortium to develop a new federated data-driven collaboration among European pediatric hospitals

GENESIS Biomed is part of the EU-funded PHEMS project consortium to develop a new federated data-driven collaboration among European pediatric hospitals

...

11 October, 2023

Renalyse has successfully closed an investment round of 1 M€ with the participation of GENESIS Ventures

Renalyse has successfully closed an investment round of 1 M€ with the participation of GENESIS Ventures

...

09 October, 2023

Closing ceremany of BIOSPAIN 2023

Closing ceremony of BIOSPAIN 2023

...

03 October, 2023

Interview with Ion Arocena

Interview with Ion Arocena – CEO at AseBio-Spanish Bioindustry Association

...

14 September, 2023

NLP in the area of health

...

31 August, 2023

The evolution of Pharmaceutical Industry Beyond the Pill

The evolution of Pharmaceutical Industry: Beyond the Pill

...

13 July, 2023

Genesis Biomed Biohub Valencia

GENESIS Biomed opens a new office in Valencia

...

20 June, 2023

GENESIS Tech Transfer Boost invests €25,000 in the biotech company Spinally Medical

GENESIS Tech Transfer Boost invests €25,000 in the biotech company Spinally Medical

...

07 June, 2023

What do they say about us?

What do they say about us?

...

23 May, 2023

Patient Engagement Platforms in chronic patient monitoring

Patient Engagement Platforms in chronic patient monitoring

...

10 May, 2023

GENESIS Biomed Sponsor of BIOSPAIN 2023

GENESIS Biomed Sponsor of BIOSPAIN 2023

...

27 April, 2023

VININ: Una nueva plataforma informará en tiempo real a los pacientes de salud mental sobre los avances de las investigaciones en las que han participado

A new platform that will inform mental health patients in real time about the progress of research in which they have taken part

...

13 April, 2023

The spin-off RetinaReadRisk has been created for marketing software and a mobile system based on artificial intelligence to detect diabetic retinopathy in the early stages

The spin-off RetinaReadRisk has been created for marketing software and a mobile system based on artificial intelligence to detect diabetic retinopathy in the early stages

...

21 March, 2023

What is meant by Off-label

What is meant by Off-label

...

08 March, 2023

Negotiating a Round in the health sector (Part 2) The roadshow and the negotiation of the deal

Negotiating a Round in the health sector (Part 2) The roadshow and the negotiation of the deal

...

23 February, 2023

DIGI-HEART: the digital cardiac mapping tool based on digital twins

DIGI-HEART: The digital cardiac mapping tool based on Digital Twins

...

01 February, 2023

GENESIS Biomed sponsors ITEMAS 2022 Annual Conference Day

GENESIS Biomed sponsors ITEMAS 2022 Annual Conference Day

...

19 January, 2023

GENESIS Biomed continues growing and adding value in biomedical sector

GENESIS Biomed continues growing and adding value in biomedical sector

...

15 December, 2022

The Investor Deck, the startup’s business card

The Investor Deck, the startup’s business card

...

23 November, 2022

Value-based medicine and Risk Sharing Agreement

Value-based medicine and Risk Sharing Agreement

...

09 November, 2022

Interview Xavier Luria - Vice-president at Veristat - regulatory consultancy firm

Interview Xavier Luria. Vice president at Veristat – regulatory consultancy firm

...

25 October, 2022

Genesis Biomed - Diabetic patients in rural areas will be able to be diagnosed with diabetic retinopathy in the early stages of the disease thanks to a mobile system

Diabetic patients in rural areas will be able to be diagnosed with diabetic retinopathy in the early stages of the disease thanks to a mobile system

...

06 October, 2022

Law of Science, the missed opportunity for spin-off creation

Law of Science, the missed opportunity for spin-off creation

...

28 September, 2022

10 projects from the Xartec Salut network are advised by GENESIS Biomed within the framework of the Venture Builder programme

...

21 September, 2022

FiSPlat, a primary care tool for liver fibrosis screening

FiSPlat, a primary care tool for liver fibrosis screening

...

08 September, 2022

Negotiating a Round in the health sector

Negotiating a Round in the health sector

...

14 July, 2022

GENESIS Biomed receives the award for the best biomedical consultancy in the XI Edition of the National Awards El Suplemento

...

21 June, 2022

Being an Entrepreneur

Being an Entrepreneur

...

15 June, 2022

Crowdfunding and Venture Capital: two complementary systems for private funding in the health sector

Crowdfunding and Venture Capital: two complementary systems for private funding in the health sector

...

25 May, 2022

Public-private collaboration in the health and research environment and some of its successes in which GENESIS Biomed has collaborated

Public-private collaboration in the health and research environment and some of its successes in which GENESIS Biomed has collaborated

...

10 May, 2022

GENESIS Biomed and FI Group create GENESIS Tech Transfer Boost

GENESIS Biomed and FI Group create GENESIS Tech Transfer Boost, a new investment vehicle that will invest in early stage projects from healthcare research

...

26 April, 2022

Interview Jordi Ortiz - Quality Manager and Senior Consultant at GENESIS Biomed

Interview Jordi Ortiz – Quality Manager and Senior Consultant at GENESIS Biomed

...

19 April, 2022

The Universidad Autónoma de Madrid launches a specific entrepreneurship programme for health researchers in collaboration with GENESIS Biomed

The Universidad Autónoma de Madrid launches a specific entrepreneurship programme for health researchers in collaboration with GENESIS Biomed

...

06 April, 2022

The European EIT Health-supported project Retina-Read-Risk will detect diabetic retinopathy through telemedicine

The European EIT Health-supported project Retina-Read-Risk will detect diabetic retinopathy through telemedicine

...

14 March, 2022

Interview Joan Carles Fernández

Interview Joan Carles Fernández – Planning Director and Senior Consultant at GENESIS Biomed

...

09 March, 2022

GENESIS Biomed supports the creation of four spin-offs during 2021

GENESIS Biomed supports the creation of four spin-offs during 2021

...

21 February, 2022

Interview Oscar Alegre - Partner at DWF-RCD

Interview Oscar Alegre – Partner at DWF-RCD (Rousaud Costas Duran) in the Innovation and Entrepreneurship Area, specialising in the Science and Technology Sector.

...

09 February, 2022

Interview Jaume Ruiz - Business Development Director and Senior Consultant at GENESIS Biomed

Interview Jaume Ruiz – Business Development Director and Senior Consultant at GENESIS Biomed

...

27 January, 2022

I3PT founds ANAIS Medical to bring professionals closer to highly realistic medical simulation for interventional procedures

I3PT founds ANAIS Medical to bring professionals closer to highly realistic medical simulation for interventional procedures

...

17 January, 2022

Jornadas anuales ITEMAS21

GENESIS Biomed sponsors the ITEMAS 2021 Annual Conference

...

15 December, 2021

Borradores de la Ley de la Ciencia y la Ley de Start-ups

Drafts of the Science Law and the Start-ups Law

...

02 December, 2021

GENESIS Biomed supports the creation of BetaScreen, the first spin-off of the Pasqual Maragall Foundation.

GENESIS Biomed supports the creation of BetaScreen, the first spin-off of the Pasqual Maragall Foundation.

...

25 November, 2021

Opening of the mowoot crowdfunding campaign with the participation of eit health: Interview with Markus Wilhelms, Daniel Oliver, Patrick Pfeffer and Natalia de la Figuera.

Opening of the Mowoot Crowdfunding campaign with the participation of EIT Health

...

10 November, 2021

Interview Xavier Canals

Interview Xavier Canals – Director Tecno-med Ingenieros, Vice-president SEEIC and independent consultant in Healthcare Technology

...

26 October, 2021

The mHealth boom in mental health

The mHealth boom in mental health

...

13 October, 2021

Progress in the maturity of the start-ups: the clinical phases

Progress in the maturity of the start-ups: the clinical phases

...

28 September, 2021

Interview Andreu Climent – Associate Founder and CEO of Corify Care.

Interview Andreu Climent – Associate Founder and CEO of Corify Care.

...

14 September, 2021

A FECYT report concludes that the entire innovation incentive scheme needs to be redesigned

A FECYT report concludes that the entire innovation incentive scheme needs to be redesigned

...

14 July, 2021

Corify Care raises €2.35M to translate its cardiac mapping technology to the market

Corify Care raises €2.35M to translate its cardiac mapping technology to the market

...

06 July, 2021

Entrevista Dr. Desco

Interview Dr. Manuel Desco – Professor of Radiology at the Carlos III University and Head of Experimental Medicine and Surgery at the Gregorio Marañón Hospital

...

01 July, 2021

Endolipid Therapeutics, the spin-off of Vall d’Hebron and GENESIS Ventures, emerges to develop a new strategy to reduce visceral and subcutaneous fat

...

17 June, 2021

Algorithms and Image Biomarkers. Radiomics as another piece of precision oncology

Algorithms and Image Biomarkers. Radiomics as another piece of precision oncology

...

02 June, 2021

GENESIS Biomed 4th Anniversary

...

28 May, 2021

Genesis Biomed - Julio Mayol

Julio Mayol: “Research is one of the key points in the response to this pandemic”

...

20 May, 2021

Liberalisation of COVID vaccine patents

...

12 May, 2021

The Gregorio Marañón Hospital creates a spin-off to market the drug that protects the kidney

The Gregorio Marañón Hospital creates a spin-off to market the drug that protects the kidney

...

10 May, 2021

GENESIS Biomed provides support to different projects in the field of in vitro fertilisation

GENESIS Biomed provides support to different projects in the field of in vitro fertilisation

...

06 May, 2021

GENESIS Biomed and DKV partner for digital health

...

30 April, 2021

Elena Torrente interview - Digital Health Development Deputy Director DKV

Elena Torrente interview – Digital Health Development Deputy Director DKV

...

29 April, 2021

GENESIS Biomed y DKV firman un acuerdo de colaboración para impulsar la salud digital

GENESIS Biomed and DKV sign a collaboration agreement to promote digital health

...

20 April, 2021

Josep Tabernero: "The covid-19 has been a revulsive to value research and I hope that this will not change when the situation improves"

Josep Tabernero: “The covid-19 has been a revulsive to value research and I hope that this will not change when the situation improves”

...

31 March, 2021

GENESIS Biomed is reinforced by hiring a top-level advisory panel

GENESIS Biomed is reinforced by hiring a top-level advisory panel

...

15 March, 2021

REGIC and Genesis Biomed

Collaboration agreement between GENESIS Biomed SL and REGIC

...

09 March, 2021

Enterprising women: an example to encourage girls in scientific careers

...

11 February, 2021

Research is the main tool we have against cancer

...

04 February, 2021

Sílvia Carrasco: “The COVID-19 pandemic has highlighted the importance of research and tech transfer”

...

27 January, 2021

Six GENESIS Biomed clients feature in the 30 principal health science funding rounds in Catalonia

...

20 January, 2021

Current Barriers to the Implementation and Exploitation of Digital and MedTech Solutions

Current Barriers to the Implementation and Exploitation of Digital and MedTech Solutions in Europe

...

18 January, 2021

Sara Secall, Inveready's Director of Investments in Life Sciences

We interview Sara Secall, Inveready’s Director of Investments in Life Sciences

...

03 December, 2020

FoodTech: new trends in food technology and health

FoodTech is a key pi...

16 October, 2020

Dr. Scott Boyer joins Chemotargets as new CEO

Dr. Scott Boyer join...

13 October, 2020

EIT Health Investors Network: a key opportunity for start-ups in search of funding

Aortyx is the 1st wi...

02 October, 2020

Alex Casta Awards ceremony

Aortyx, winner of Àlex Casta Awards to the best pitch of the Catalan Bioregion

Aortyx is the 1st wi...

29 September, 2020

Jordi Martorell, CEO de Aortyx

“Having a good understanding with your team is essential: they will make your company grow”

Aortyx's pre-clinica...

17 September, 2020

Marta Barrachina y management team de Admit.

Marta Barrachina: “I am confident that there will be advances in Alzheimer’s in the short term”

ADmit Therapeutics c...

14 September, 2020

The great entrepreneurship moment of Madrid healthcare ecosystem

Madrid region is liv...

08 September, 2020

Joan Roca: “As chefs we have a great responsibility”

Interview with Joan ...

23 July, 2020